Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title:Subject Index To Volume 1
Volume: 2 Issue: 1
Author(s): Science Publishers Bentham and Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Publishers Science and Bentham Science Publishers , Subject Index To Volume 1, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2002; 2 (1) . https://dx.doi.org/10.2174/1568008024606275
DOI https://dx.doi.org/10.2174/1568008024606275 |
Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5917 |
11
Related Articles
-
Metabolomics of Serum Peptides
Protein & Peptide Letters From the Sea to Anticancer Therapy
Current Medicinal Chemistry Emerging Immunotargets in Metastatic Renal Cell Carcinoma
Current Drug Targets Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy
Current Topics in Medicinal Chemistry The Molecular Recognition Paradigm of Environmental Chemicals with Biomacromolecules
Current Protein & Peptide Science Better Targeting Melanoma: Options Beyond Surgery and Conventional Chemotherapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Aging and Oral Health: Effects in Hard and Soft Tissues
Current Pharmaceutical Design Molecular Pathways Involved in Apoptotic Cell Death in the Injured Cochlea: Cues to Novel Therapeutic Strategies
Current Pharmaceutical Design Herbal and Traditional Chinese Medicine for the Treatment of Cardiovascular Complications in Diabetes Mellitus
Current Diabetes Reviews Simulation of Microgravity for Studies in Gravitational Biology: Principles, Devices and Applications
Current Biotechnology Proteases and Their Role in Chronic Inflammatory Lung Diseases
Current Drug Targets Docking: Successes and Challenges
Current Pharmaceutical Design The Colostrum Proteome, Ruminant Nutrition and Immunity: A Review
Current Protein & Peptide Science Lipoprotein(a): Medical Treatment Options for an Elusive Molecule
Current Pharmaceutical Design Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets Prediction of the Estrogen Receptor Binding Affinity for both hER<sub>α</sub> and hER<sub>β</sub> by QSAR Approaches
Letters in Drug Design & Discovery Bench to Bedside of CTLA-4: A Novel Immuno-Therapeutic Agent for Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Hypocalcemia Induced by Raloxifene
Current Drug Safety 7-Difluoromethyl-5, 4’-Dimethoxygenistein Reverses LPC-Induced Apoptosis of HUVE-12 Cells Through Regulating Mitochondrial Apoptosis Pathway
Current Signal Transduction Therapy Graphical Abstracts:
Current Radiopharmaceuticals